Krane Funds Advisors’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CCM
GCM
RIM
KCM
SCA
Krane Funds Advisors's LMAT Position: Q1 2022 in Review
Krane Funds Advisors sold out of LeMaitre Vascular (LMAT) in Q1 2022, closing a stake of 15,353 shares — an estimated $771K sold.
Krane Funds Advisors first reported a position in LMAT in Q2 2021 and held it in 3 quarters. The position peaked at $927K in Q2 2021. 183 funds tracked by Wall St. Rank hold LMAT as of Q1 2022.
- Krane Funds Advisors reported no remaining LeMaitre Vascular position as of Q1 2022 after selling out during the quarter.
- Krane Funds Advisors sold 15,353 LeMaitre Vascular shares in Q1 2022, an estimated $771K.
- Krane Funds Advisors first reported a position in LeMaitre Vascular in Q2 2021 and held it in 3 quarters.
- Krane Funds Advisors's LeMaitre Vascular position peaked at $927K in Q2 2021.
- 183 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2022.
Based on Krane Funds Advisors's 13F filing for Q1 2022, filed 11 May 2022.